Servier and NiKem Research Srl announced the signature of a Discovery Research Service Agreement. Under the terms of the agreement NiKem will, in the next 12 months, use its medicinal chemistry …
Podobne wpisyChristiaan De Wilde succeeds Frank Morich as Innogenetics’ CEOThe Innogenetics Board of Directors has named Chief Financial Officer (CFO) Christiaan De Wilde as t…Clavis Pharma Completes Executive Management TeamClavis Pharma ASA announced the appointment of Jan Alfheim as Chief Business Officer. Mr. Alfheim ha…MedImmune and Crucell jointly develop new antibodies for the treatment and prevention of hospital-acquired bacterial infectionMedImmune and Crucell N.V. announced that they have entered into an exclusive license and research c…Booze is where drug problem startsCousins insult the catalyst for Lions
This entry was posted on Wednesday, October 17th, 2007 at 1:34 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. RSS 2.0. Both comments and pings are currently closed.